Clinical and Genetic Analysis of Korean Patients with Facioscapulohumeral Muscular Dystrophy

被引:4
作者
Ki, Chang-Seok [2 ]
Lee, Seung-Tae [2 ]
Kim, Kyung-Sook [2 ]
Kim, Jong-Won [2 ]
Hong, Yoon-Ho [1 ]
Sung, Jung-Joon [1 ]
Park, Kyung Seok [1 ]
Lee, Kwang-Woo [1 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea
关键词
Facioscapulohumeral Muscular Dystrophy; FSHD; D4Z4; Korean;
D O I
10.3346/jkms.2008.23.6.959
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominantly inherited muscular disorder, which is characterized by weakness of facial, shoulder and hip girdle, humeral, and anterior distal leg muscles. The FSHD gene has been mapped to 4q35 and a deletion of integral copies of a 3.3-kb DNA repeat motif named D4Z4 was known to be the genetic background of the disorder. Although FSHD is the second most common muscular dystrophy in adulthood, there were few reports on the genetically confirmed patients in Korea. Recently, we experienced four Korean patients with clinical features resembling FSHD. In order to confirm the diagnosis, conventional Southern blot (SB) analysis by using double digestion with EcoRl and Blnl and hybridization with p13E-11 probe was performed in three patients and newly developed long polymerase chain reaction (PCR) method was used for one patient because genomic DNA was not enough for conventional SB for this patient. All patients were demonstrated to have shortened D4Z4 repeats that were consistent with FSHD. Therefore, we could confirm the diagnosis of FSHD in four Korean patients and appropriate genetic counseling was done for the patients and their families. It is of note that long-PCR method could be a good alternative for conventional SB when D4Z4 repeats were less than 5.
引用
收藏
页码:959 / 963
页数:5
相关论文
共 28 条
  • [1] CHOI CU, 1991, J KOREAN ORTHOP ASS, V26, P1354
  • [2] CHOI YH, 1993, J KOREAN NEUROL ASS, V11, P121
  • [3] Felice KJ, 2001, MUSCLE NERVE, V24, P352, DOI 10.1002/1097-4598(200103)24:3<352::AID-MUS1005>3.0.CO
  • [4] 2-M
  • [5] H2-DMα-/- mice show the importance of major histocompatibility complex-bound peptide in cardiac allograft rejection
    Felix, NJ
    Brickey, WJ
    Griffiths, R
    Zhang, JH
    Van Kaer, L
    Coffman, T
    Ting, JPY
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) : 31 - 40
  • [6] Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy
    Goto, K
    Nishino, I
    Hayashi, YK
    [J]. NEUROMUSCULAR DISORDERS, 2006, 16 (04) : 256 - 261
  • [7] Very low penetrance in 85 Japanese families with facioscapulohumeral muscular dystrophy 1A
    Goto, K
    Nishino, I
    Hayashi, YK
    [J]. JOURNAL OF MEDICAL GENETICS, 2004, 41 (01) : e12
  • [8] ANALYSIS OF THE TANDEM REPEAT LOCUS D4Z4 ASSOCIATED WITH FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY
    HEWITT, JE
    LYLE, R
    CLARK, LN
    VALLELEY, EM
    WRIGHT, TJ
    WIJMENGA, C
    VANDEUTEKOM, JCT
    FRANCIS, F
    SHARPE, PT
    HOFKER, M
    FRANTS, RR
    WILLIAMSON, R
    [J]. HUMAN MOLECULAR GENETICS, 1994, 3 (08) : 1287 - 1295
  • [9] Facioscapulohumeral muscular dystrophy molecular testing using a non radioactive protocol
    Kekou, K
    Fryssira, H
    Sophocleous, C
    Mavrou, A
    Manta, P
    Metaxotou, C
    [J]. MOLECULAR AND CELLULAR PROBES, 2005, 19 (06) : 422 - 424
  • [10] Facioscapulohumeral dystrophy
    Kissel, JT
    [J]. SEMINARS IN NEUROLOGY, 1999, 19 (01) : 35 - 43